Nuvation Bio Inc

{ "date": [ "202612", "202712", "202812", "202912", "203012" ], "revenue_estimate": [ 202.76, 290.23, 425.44, 594.11, 938.62 ], "ebit_estimate": [ -128.49, -92.04, 4.76, 60.97, 234.46 ], "ebitda_estimate": [ -120.56, -35.14, -24.61, null, null ], "net_income_estimate": [ -106.86, -85.55, -5.05, 73.22, 245.55 ], "per_share_eps_estimate": [ -0.45, -0.25, 0, 0.15, 0.73 ], "eps_nri_estimate": [ -0.45, -0.24, 0, 0.15, 0.73 ], "dividend_estimate": [ null, null, null, null, null ], "book_value_per_share_estimate": [ 0.67, 0.66, 0.68, null, null ], "pretax_income_estimate": [ -118.53, -85.55, -5.05, 61.08, 320.35 ], "operating_cash_flow_per_share_estimate": [ -0.33, -0.55, -0.08, 0.16, null ], "roa_estimate": [ null, null, null, null, null ], "roe_estimate": [ -42.7, -17.43, -13.02, null, null ], "gross_margin_estimate": [ 91.17, 90, 90, 97, null ], "operating_cash_flow_estimate": [ -124.58, -207.64, -30.2, 60.4, null ], "pettm_estimate": [ 0, 0, 1936.67, 38.22, 7.96 ], "long_term_growth_rate_mean": 0, "long_term_revenue_growth_rate_mean": "83.92", "future_per_share_eps_estimate_growth": null, "future_eps_nri_estimate_growth": null, "future_revenue_estimate_growth": 83.92, "future_ebit_estimate_growth": null, "future_ebitda_estimate_growth": 53.74, "future_dividend_estimate_growth": null, "future_net_income_estimate_growth": 67.78, "future_pretax_income_estimate_growth": 68.12, "future_book_value_per_share_estimate_growth": -7.65, "future_roa_estimate_growth": null, "future_roe_estimate_growth": 40.06, "future_gross_margin_estimate_growth": null, "future_operating_cash_flow_per_share_estimate_growth": 39.63 }

{ "date": [ "202606", "202609", "202612", "202703", "202706", "202709", "202712", "202803" ], "revenue_estimate": [ 27.3, 39.39, 54.74, 74.67, 71.82, 71.72, 82.38, null ], "ebit_estimate": [ -52.32, -44.14, -35.8, null, null, null, null, null ], "ebitda_estimate": [ null, null, null, null, null, null, null, null ], "net_income_estimate": [ -48.65, -40.96, -33.02, null, null, null, null, null ], "per_share_eps_estimate": [ -0.19, -0.15, -0.13, -0.05, -0.06, -0.07, -0.05, 0.03 ], "eps_nri_estimate": [ -0.18, -0.15, -0.13, -0.04, -0.06, -0.07, -0.05, 0.03 ], "dividend_estimate": [ null, null, null, null, null, null, null, null ], "book_value_per_share_estimate": [ null, null, null, null, null, null, null, null ], "pretax_income_estimate": [ -48.65, -40.96, -33.02, null, null, null, null, null ], "operating_cash_flow_per_share_estimate": [ null, null, null, null, null, null, null, null ], "roa_estimate": [ null, null, null, null, null, null, null, null ], "roe_estimate": [ null, null, null, null, null, null, null, null ], "gross_margin_estimate": [ 90, 90, 90, null, null, null, null, null ], "operating_cash_flow_estimate": [ null, null, null, null, null, null, null, null ], "pettm_estimate": [ 0, 0, 0, 0, 0, null, null, null ], "long_term_growth_rate_mean": 0, "long_term_revenue_growth_rate_mean": "83.92", "future_per_share_eps_estimate_growth": null, "future_eps_nri_estimate_growth": null, "future_revenue_estimate_growth": 83.92, "future_ebit_estimate_growth": null, "future_ebitda_estimate_growth": 53.74, "future_dividend_estimate_growth": null, "future_net_income_estimate_growth": 67.78, "future_pretax_income_estimate_growth": 68.12, "future_book_value_per_share_estimate_growth": -7.65, "future_roa_estimate_growth": null, "future_roe_estimate_growth": 40.06, "future_gross_margin_estimate_growth": null, "future_operating_cash_flow_per_share_estimate_growth": 39.63 }